These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38749427)

  • 1. Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.
    Xu ZM; Gnouamozi GE; Rüeger S; Shea PR; Buti M; Chan HL; Marcellin P; Lawless D; Naret O; Zeller M; Schneuing A; Scheck A; Junier T; Moradpour D; Podlaha O; Suri V; Gaggar A; Subramanian M; Correia B; Gfeller D; Urban S; Fellay J
    Am J Hum Genet; 2024 Jun; 111(6):1018-1034. PubMed ID: 38749427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.
    Casillas R; Tabernero D; Gregori J; Belmonte I; Cortese MF; González C; Riveiro-Barciela M; López RM; Quer J; Esteban R; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2018 Feb; 24(6):680-692. PubMed ID: 29456407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
    Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
    Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Treeprasertsuk S; Tanwandee T; Charatcharoenwitthaya P; Thongsawat S; Leerapun A; Piratvisuth T; Boonsirichan R; Bunchorntavakul C; Pattanasirigool C; Pornthisarn B; Tuntipanichteerakul S; Sripariwuth E; Jeamsripong W; Sanpajit T; Poovorawan Y; Komolmit P
    Antivir Ther; 2018; 23(1):67-75. PubMed ID: 28635613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
    Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
    J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection
    Lee J; Zong L; Krotow A; Qin Y; Jia L; Zhang J; Tong S; Li J
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.
    Takeuchi JS; Fukano K; Iwamoto M; Tsukuda S; Suzuki R; Aizaki H; Muramatsu M; Wakita T; Sureau C; Watashi K
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
    Iwamoto M; Saso W; Sugiyama R; Ishii K; Ohki M; Nagamori S; Suzuki R; Aizaki H; Ryo A; Yun JH; Park SY; Ohtani N; Muramatsu M; Iwami S; Tanaka Y; Sureau C; Wakita T; Watashi K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8487-8492. PubMed ID: 30952782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    Zhang J; Wang Q; Yuan W; Li J; Yuan Q; Zhang J; Xia N; Wang Y; Li J; Tong S
    J Virol; 2024 Aug; 98(8):e0192923. PubMed ID: 39078152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicities and Species Specificities of Hepadnaviruses in Primates, Rodents, and Bats.
    Jacquet S; Pons JB; De Bernardo A; Ngoubangoye B; Cosset FL; Régis C; Etienne L; Pontier D
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
    Tsukuda S; Watashi K; Iwamoto M; Suzuki R; Aizaki H; Okada M; Sugiyama M; Kojima S; Tanaka Y; Mizokami M; Li J; Tong S; Wakita T
    J Biol Chem; 2015 Feb; 290(9):5673-84. PubMed ID: 25550158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; He W; Zhong G; Qi Y; Ren B; Gao Z; Jing Z; Song M; Xu G; Sui J; Li W
    J Virol; 2013 Jul; 87(14):7977-91. PubMed ID: 23678176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
    J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.